Nalls Sherbakoff Group, LLC Pacific Biosciences Of California, Inc. Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 34 shares of PACB stock, worth $66. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 34
-0.0%
Holding current value
$66
Previous $284,000
17.61%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
254Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$65.1 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$46 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$45.6 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$39.6 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$34.4 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $438M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...